Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto S Pappo

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2025
Erratum: Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal TumorsLeo Mascarenhas, Steven G DuBois, Catherine M Albert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2017
Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697)Sanjiv S Agarwala, Sandra J Lee, Waiki Yip, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2025
Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal TumorsLeo Mascarenhas, Steven G DuBois, Catherine M Albert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2019
A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk NeuroblastomaWayne L Furman, Sara M Federico, Mary Beth McCarville, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 24, 2014
Adolescent and young adult oncology, version 2.2014Peter F Coccia, Alberto S Pappo, Jessica Altman, et al.
Leukemia|November 10, 2024
Genomic profiling of circulating tumor DNA for childhood cancersShaohua Lei, Sujuan Jia, Sunitha Takalkar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2012
Adolescent and young adult oncology. Clinical practice guidelines in oncologyPeter F Coccia, Jessica Altman, Smita Bhatia, et al.
The Lancet. Oncology|February 28, 2020
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trialsDavid S Hong, Steven G DuBois, Shivaani Kummar, et al.
Cold Spring Harbor Molecular Case Studies|October 13, 2019
Enrichment of heterozygous germline <i>RECQL4</i> loss-of-function variants in pediatric osteosarcomaJamie L Maciaszek, Ninad Oak, Wenan Chen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2016
Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in OncologyMargaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2025
Erratum: Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal TumorsLeo Mascarenhas, Steven G DuBois, Catherine M Albert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2017
Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697)Sanjiv S Agarwala, Sandra J Lee, Waiki Yip, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2025
Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal TumorsLeo Mascarenhas, Steven G DuBois, Catherine M Albert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2019
A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk NeuroblastomaWayne L Furman, Sara M Federico, Mary Beth McCarville, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 24, 2014
Adolescent and young adult oncology, version 2.2014Peter F Coccia, Alberto S Pappo, Jessica Altman, et al.
Leukemia|November 10, 2024
Genomic profiling of circulating tumor DNA for childhood cancersShaohua Lei, Sujuan Jia, Sunitha Takalkar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2012
Adolescent and young adult oncology. Clinical practice guidelines in oncologyPeter F Coccia, Jessica Altman, Smita Bhatia, et al.
The Lancet. Oncology|February 28, 2020
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trialsDavid S Hong, Steven G DuBois, Shivaani Kummar, et al.
Cold Spring Harbor Molecular Case Studies|October 13, 2019
Enrichment of heterozygous germline <i>RECQL4</i> loss-of-function variants in pediatric osteosarcomaJamie L Maciaszek, Ninad Oak, Wenan Chen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2016
Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in OncologyMargaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
Pageof 14